Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 822 results for "merck co"

Merck & Co. (MRK) Scheduled to Post Earnings on Tuesday
Ticker Report

Merck Has An Upcoming PDUFA Date For Bezlotoxumab

Merck & Co., Inc. (NYSE: MRK ) announced it has an upcoming PDUFA date on October 23. The FDA has accepted for review Merck's Biologics License application for Bezlotoxumab, an investigational antitoxin for the prevention of Clostridium difficile ..., 2 hours ago
Analysts Weekly Ratings Changes for Merck & Co. (MRK) American Banking News, 3 hours ago

157 images for merck co

Ticker Report, 14 hours ago
Ticker Report, 2 days ago
American Banking News, 1 hour ago
American Banking News, 4 days ago, 1 day ago
WKRB News, 2 weeks ago, 1 week ago
Live Trading News, 3 weeks ago
The Nation Pakistan, 1 week ago
IChainnel, 2 weeks ago

Are The Drugs Working? Pharma Giants Eli Lilly And Merck To Update Investors On Cancer Treatments

When it comes to big pharmaceutical companies, there look to be few things more alluring than new treatments for cancer, according to analysts who follow drug tests closely. Tuesday's lineup of earnings reports features Eli Lilly and Co (NYSE: LLY ) ...
 Benzinga.com7 hours ago

Merck's Keytruda Study in Bladder Cancer Stopped as Goal Met

Merck & Co.'s study of its Keytruda drug in patients with previously treated bladder cancer was stopped on the recommendation of a panel after hitting its primary goal in overall survival. Keytruda was superior compared to standard chemotherapy in ...
 Bloomberg5 hours ago Merck's immunotherapy drug succeeds in key bladder cancer trial  Yahoo! Finance12 hours ago Merck & Co.'s Keytruda shows survival benefit versus chemotherapy in advanced urothelial cancer: study  FirstWord Pharma12 hours ago Advaxis Initiates Combination Portion Of Phase I/II Study With Merck & Co.  BioSpace1 day ago

Merck's Keytruda successful in late-stage bladder cancer study

A Phase 3 clinical trial, KEYNOTE-045, assessing Merck's (NYSE: MRK ) PD-1 inhibitor KEYTRUDA (pembrolizumab) in treatment-experienced patients with advance urothelial cancer has been stopped early after the independent Data Monitoring Committee ...
 Seeking Alpha11 hours ago Merck's Keytruda Wows in Bladder Cancer Trial  Pharma Live4 hours ago Merck's Keytruda hits endpoints in Phase III advanced bladder cancer trial  Pharma Letter6 hours ago Merck's Phase 3 Trial Studying Urothelial Cancer Treatment Meets Primary Endpoint & Stops Early  PharmaceuticalProcessing6 hours ago

Jim Cramer Gives His Opinion On Merck And Smith & Wesson

On CNBC's Mad Money , Jim Cramer spoke about Merck & Co., Inc. (NYSE: MRK ). He thinks that the stock would be trading around $65 or $66 on the good news about its drug Keytruda, if there were no political worries. If it doesn't get contested after ...
 Benzinga.com11 hours ago

Debiopharm teams up with Merck KGaA and Pfizer in lung cancer

Switzerland's Debiopharm has announced a collaboration withGermany's Merck and Pfizer to evaluate Debio 1143, in combination with avelumab, in patients with advanced or metastatic non-small cell lung cancer (NSCLC). The companies aim to combine ...
 pharmaphorum7 hours ago Debiopharm International SA annonce sa collaboration clinique avec Merck KGaA, Darmstadt, Allemagne, et Pfizer dans l'immunoth√©rapie du cancer  Canada NewsWire1 day ago Debiopharm International SA Announces Clinical Collaboration with the Merck-Pfizer Alliance in Cancer..  ADVFN India1 day ago Debiopharm Announces Clinical Collaboration With Merck KGaA, Darmstadt, Germany, And Pfizer In Cancer Immunotherapy  BioSpace1 day ago

Analysts Recommendations Trending Stocks: Merck & Co., Inc. (NYSE:MRK) & Union Pacific Corporation (NYSE:UNP)

On Thursday, Shares of Merck & Co., Inc. (NYSE:MRK) gained 0.08% to $61.92. The share price is trading in a range of $61.69 62.26. The stock exchanged hands with 6.32 million shares contrast to its average daily volume of 10.48 million shares. ...
 News Is Money10 hours ago Nothing Can Stop Merck & Co., Inc. (MRK) Stock Now  InvestorPlace.com1 day ago HC Stocks Overview! Johnson & Johnson (JNJ), Merck & Co. Inc. (MRK)  Share Market Updates3 days ago Buy Merck on Drops to $60  Yahoo! Finance4 days ago

The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals

For Immediate Release Chicago, IL October 21, 2016 announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial ...
 Yahoo! Singapore8 hours ago

Merck's letermovir successful in preventing CMV infection in late-stage study

A Phase 3 clinical trial assessing Merck's (NYSE: MRK ) letermovir (MK-8228) for preventing clinically significant cytomegalovirus (CMV) infection in CMV-seropositive adults who have undergone an allogeneic hematopoietic stem cell transplant (HSCT) ...
 Seeking Alpha2 days ago Merck's letermovir succeeds in preventing CMV infection in phase 3 study  Pharmaceutical Business Review1 day ago

Merck's antiviral drug meets main goal in late-stage trial

Oct 19 (Reuters) - Merck & Co Inc said its experimental drug to prevent cytomegalovirus infection in high-risk bone marrow transplant patients met its primary goal in a late-stage trial. Cytomegalovirus is a member of the herpes virus family and ...
 Yahoo! Finance2 days ago UPDATE 1-Merck's antiviral drug meets main goal in late-stage trial  Business Insider1 day ago Merck's antiviral drug meets goal in late-stage trial  Pharma Live2 days ago Merck scraps development of osteoporosis drug due to stroke risk  Reuters1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less